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OBJECTIVE OF THE WORK 
 
During the past 20 years it has been reported that between 6 
-14% of patients enter general hospitals develop a nosocomial 
infection. Overall, upto of 60% of all nosocomial infections are due 
to biofilms. This makes biofilm-related infections a major cause of 
morbidity and mortality and frequently the only solution to an 
infected implanted device is its surgical removal which bears 
additional economic and health costs. The ability of biofilm 
formation is one of the most important virulence factors occurring 
in microbes.  The Staphylococcus species is one of the most 
important etiologic agents of hospital infections associated with 
biofilm formation on different indwelling medical devices. 
 
          A wide range of antimicrobial compounds are used to 
remove biofilm structure e.g. antibiotics, disinfectants or 
antiseptics and other non-antibiotic agents; their effectiveness 
depends on the properties of the biofilm forming bacteria and also 
the age of biofilm. Medical devices treatment with antimicrobial 
agents and antimicrobial locks are some methods involved in the 
destruction of matured biofilm or prevention of its formation.  
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Thus the objectives of our study were   
 
 To study biofilm forming abilities of certain Staphylococcal 
sp. by various methods like: Tissue Culture Plate method 
(TCP), Tube Method (TM) and Congo Red Agar method 
(CRA). 
 
 To study the duration of adhesion and biofilm formation on 
biomaterial in-vitro by TTC method.  
 
 To quantify the biofilm formation by using Crystal Violet 
method.  
 
 Determination of Minimal Inhibitory Concentration (MIC) 
of Ofloxacin and Rifampin by broth dilution method and 
evaluate the effects of Ofloxacin and Rifampin on Adhesion, 
biofilm formation and eradication of mature biofilm on 
biomaterial in- vitro by TTC method.  
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SCHEME OF WORK 
 
                  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Collection of Staphylococci species
Identification of biofilm formation by Tissue Culture Method,  
Tube Method, Congo Red Agar method
Determination of adhesion duration on biomaterial  
by TTC Method
Quantification of biofilm by Crystal Violet method 
In-vitro MIC and MBC Determination of Ofloxacin 
and Rifampin
Determination of MIC of Ofloxacin and Rifampin in 
 preventing adhesion on biomaterial by TTC Method 
Determination of MIC of Ofloxacin and Rifampin in 
preventing formation of biofilm on biomaterial by TTC Method 
Determination of MIC of Ofloxacin and Rifampin 
to eradicate mature biofilm on biomaterial by TTC Method 
Determination of biofilm formation on biomaterial  
by TTC Method
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ABSTRACT 
 
 In our study, biofilm forming ability of 
Staphylococcal sp. was screened by using Tissue 
Culture Plate method (TCP), Tube Method (TM) and 
Congo Red Agar (CRA) methods. The biofilm forming 
abilities of three Staphylococcal sp. designated S-II, S-III 
and S-IV were compared with reference strain S-I. S-II 
exhibited strong biofilm producing ability when studied 
using all the three methods. The strain S-III exhibited 
strong biofilm producing ability in TCP and TM method 
but biofilm producing ability was poor as studied by 
CRA method.  The strain S-IV exhibited moderate biofim 
producing ability in TCP method but biofilm producing 
ability was poor in TM and CRA methods.  The adhesion 
process and biofilm formation on biomaterial were 
determined using 2, 3, 5 Triphenyl Tetrazolium Chloride 
(TTC) method. All strains were able to form biofilm on 
biomaterial between 72 to 96 hrs, irrespective of 
adhesion duration (S-I 12hrs, S-II 24hrs, S-III 24hrs and S-IV 
48hrs). The concentration range of Ofloxacin in 
preventing adhesion process was found to be 3.9 to 
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62.5µg/ml. Biofilm formation was prevented at 15.6 to 
125 µg/ml and to eradicate mature biofilm on 
biomaterial, 125 to 500 µg/ml was needed against all 
strains. The concentration range of Rifampin in 
preventing adhesion process was found to be 0.04 to 
0.78µg/ml. Biofilm formation was prevented at 0.78 to 
3.12 µg/ml and to eradicate mature biofilm on 
biomaterial 6.25 to 25 µg/ml concentrations was 
needed against all strains.  
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INTRODUCTION 
  
The successes of modern medicine are closely 
linked to the ever-increasing use of implanted 
biomedical devices for the intermittent or permanent 
substitution of failing organs or for management of vital 
functions of critically ill patients in the intensive care 
unit. A major complication of the use of these devices is 
infection affecting upto millions of patients worldwide 
each year. Biomaterial-associated infections are 
caused in most instances by Staphylococci, mostly 
Staphylococcus epidermidis and Staphylococcus 
aureus, and do not respond properly to antimicrobial 
treatment, regularly requiring the removal of the 
infected biomaterial and leading to substantial 
morbidity and mortality (Mack D., et al 2004). 
 
In the 17th century, the discovery of microbial 
biofilms can be attributed to Anton van Leeuwenhoek, 
who first observed microorganisms in the plaque on his 
own teeth, using his simple microscope. Later, in the 20th 
century, Heukelekian and Heller in 1940 and Zobell in 
1943 showed that bacterial growth and activity were 
 17 
considerably enhanced by the presence of a surface 
to which bacteria could attach and that the number of 
microorganisms on surfaces was significantly higher 
than in the surrounding medium (Costerton, 1999). 
  
 
 
 
The   biofilm can be defined as a community of 
bacteria, that is irreversibly attached to a biotic or 
abiotic surface and that is enclosed in a matrix of 
exopolymeric products. This matrix is composed of a 
mixture of extracellular polymeric substances (EPS), 
such as polysaccharides, proteins, nucleic acids and 
other substances (Donalan R.M et al., 2002). 
 
Bacteria and the need to form Biofilm  
According to Darwin’s theory of evolution, the 
only true driving force behind the course of action of 
any organism is reproductive fitness. Any action that 
increases proliferation will endure within a species. 
Therefore, when we talk about the driving force behind 
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biofilm formation we are asking the question ‘‘How 
does the biofilm mode of growth promote survival and 
propagation of the cell?’’ It almost seems counter-
intuitive that the biofilm mode of growth could confer 
productive fitness advantage when one considers that 
biofilm bacteria have a reduced rate of growth relative 
to bacteria growing planktonically in broth culture. 
Outside of the laboratory, however, bacteria rarely, if 
ever, find themselves in an environment as nutrient rich 
as culture media and in these less-than-ideal 
conditions, there are a number of fitness advantages 
imparted by the biofilm mode of growth. The formation 
of bacterial biofilms must, necessarily, begin with the 
adhesion of a small number of bacterial cells to a 
surface. Many laboratory-adapted strains have virtually 
lost their ability to adhere to surfaces because, each 
time they are transferred into fresh medium, the 
inoculum for this operation is taken from the bulk fluid 
and any bacterial cells that are adherent to the walls of 
the vessel are left behind (Jefferson K.K., 2004). 
 
Process of biofilm formation 
Attachment. 
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Microcolony formation. 
Formation of three-dimensional structure and 
maturation. 
Detachment . 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1:s Schematic representation of steps in biofilm  
formation and its consequences 
 20 
 
Attachment 
The initial microbial adherence is mostly 
dependent on bacterial cell surface characteristics 
and the nature of the material surface. In its most 
fundamental form, bacterial adhesion can be divided 
into two main phases: Primary or Docking phase and 
the Secondary or locking phase. In some cases, an 
additional surface conditioning step is added to this 
process Conditioning occurs when the biomaterial is 
inserted in the human body and interacts with the 
surrounding environment. As a result, the native surface 
is modified by the adsorption of host-derived matrix 
proteins such as albumin, fibronectin or fibrinogen. 
When this process occurs, surface properties become 
permanently altered, in a way that the affinity of an 
organism for a conditioned surface can be quite 
different than for a naked one.  
 
Primary adhesion is a reversible stage that occurs 
when the bacterial cells first meet the surface. This is 
determined by a number of physiochemical variables 
that define the interaction between the bacterial cell 
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surface and the conditioned surface of interest.  First, 
the organism approaches the surface, either randomly 
or directed by chemotaxis and motility and when it 
reaches a  
critical proximity to the surface (usually <1 nm), the final 
determination of adhesion depends on the net sum of 
attractive or repulsive forces generated between the 
two surfaces. These forces include electrostatic 
hydrophobic interactions, Van der Waals forces and 
acid-base interactions. Electrostatic interactions are 
likely to favor repulsion, because most bacteria and 
inert surfaces are negatively charged. The physical 
interactions are further classified as long-range and 
short-range interactions. The non-specific long-range 
forces include Van der Waals forces, electrostatic 
forces, acid-base interactions, and Brownian motion 
forces and are a function of the distance and free 
energy (distances >50 nm)  Short-range specific 
interactions operate in highly localized regions of the 
interacting surfaces (distances <5nm) and include 
hydrogen bonding, ionic and dipole interactions. In 
accordance, as reported by Marshall  in 1985, at 
separation distances greater than approximately 50 
nm, Van der Waals forces are the only ones operative 
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since this distance is considered to be too large for the 
opposing surfaces to recognize specific surface 
components. However, at separation distances 
between approximately 10 and 20 nm, only secondary 
minimum interactions occur as a result of Van der 
Waals and electrical double layer forces and adhesion 
is probably reversible. At separation distances of less 
than about 1.5 nm, a great variety of specific or 
nonspecific short range forces can occur, leading to 
irreversible adhesion. Cell and substratum surfaces 
hydrophobicity can here play a major role in removing 
water films between the interacting surfaces enabling 
short-range interactions to occur. Roughness and 
chemical composition of the biomaterial surface itself 
are also important parameters involved in this initial 
stage of adhesion  
 
The second stage of adhesion is the anchoring or 
locking phase and employs molecularly mediated 
binding between specific adhesions and the surface. 
All bacteria produce multiple adhesions, and some are 
regulated at the transcriptional level, permitting 
organisms to switch from sessile to planktonic forms 
under different environmental influences. At this point, 
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loosely bound organisms consolidate the adhesion 
process by producing exopolysaccharide that complex 
with surface materials and/or receptor-specific ligands 
located on pili and fimbriae or both (An Y.H et al., 1997, 
Dunne W.M, 2002). 
 
Micro colony formation  
After the bacteria adhere to the inert 
surface/living tissue, the association becomes stable for 
microcolony formation. The bacteria begin to multiply 
while emitting chemical signals that intercommunicate 
among the bacterial cells. Once the signal intensity 
exceeds a certain threshold level, the genetic 
mechanisms underlying exopolysaccharide production 
are activated. In this way, the bacteria multiply within 
the embedded exopolysaccharide matrix, thus giving 
rise to the formation of a microcolony. 
 
Formation of three-dimensional structure and 
maturation 
During the attachment phase of biofilm 
development, perhaps after microcolony formation, 
 24 
the transcription of specific genes takes place. These 
are required for the synthesis of EPS. Attachment itself 
can initiate synthesis of the extracellular matrix in which 
the sessile bacteria are embedded, followed by 
formation of water-filled channels. It has been 
proposed that these channels constitute primitive 
circulatory systems, delivering nutrients to and removing 
waste products from the communities of cells in the 
microcolonies. 
 
Detachment 
 Mature biofilms can then undergo a detachment 
process, due to the exposure to strong mechanical and 
hydrodynamic forces and to quorum sensing 
regulation, releasing planktonic bacteria that can then 
colonize another region of the substratum to form new 
microcolonies (Prakash B. et al., 2003).  
 
Composition of biofilm 
Concerning the biofilm composition water is 
considered to be the major component of the biofilm 
matrix up to 97% while bacteria occupy only between 
10 to 50% of the total volume of the biofilm. EPS 
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account for 50 to 90% of the total organic carbon of 
biofilms. Besides polysaccharides, proteins, nucleic 
acids or phospholipids, non cellular materials such as 
mineral crystals, corrosion particles or blood 
components, depending on the environment in which 
the biofilm has developed, may also be found in the 
biofilm matrix. 
    
 
 
 
 
Fig.2: Composition of biofilm 
 
In biofilms, the cells exchange information by 
signals, denominated “quorum sensing”, which are 
chemical signals, used to regulate cell density-
dependent gene expression. The quorum sensing signal 
molecules are peptides, comparable to pheromones 
and hormones that controls cell division and thereby 
the biofilm population density as well as the production 
of exopolymeric matrix (Donlan R.M et al., 2002). 
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Regulation of biofilm formation 
Substratum Effect 
The  extent  of  microbial  colonization appears  to 
increase as the surface roughness increases due to the 
diminished surface  area  and higher  surface area  on 
rougher  surfaces. Maximum   attachment   depends 
upon high surface   free   energy   or wettability of 
surfaces. Surfaces   with high surface   free   energies 
such as stainless steel and glass are more hydrophilic. 
These   surfaces generally show greater bacterial 
attachment than hydrophobic surfaces such as Teflon, 
Buna-n rubber and fluorinated hydrocarbon.   
 
Conditioning Film 
Solid surfaces which have been exposed in an 
aqueous medium become conditioned or coated with 
polymers from the medium. The chemical modification 
of surfaces affects the rate and extent of microbial 
attachment. The surface is converted to hydrophilic by 
cleaning with alkali or strong acid (4M nitric  acid)  of  
 27 
stainless  steel  surfaces. Once  the stainless  steel  is  
exposed to air  or  water, it  is passivated by  the  
formation of  a  chromium  oxide layer. Organic soil 
adheres to the oxide layer, producing a conditioned 
substratum to which bacteria adhere.  Another prime 
example is “acquired pellicle” which develops on tooth 
enamel surfaces in oral cavity. It consists of albumin, 
lysozyme, glycoprotein, phosphoproteins, lipids and 
gingival screvice fluid. Bacteria, from oral cavity, 
colonize pellicle-conditioned surfaces within hours of 
exposure to these surfaces. A number of host-produced 
conditioning films such as blood, saliva, tears, urine, 
intravascular fluid and respiratory secretions influence. 
The attachment of bacteria to biomaterials. The surface 
energy of the suspending medium may affect 
hydrodynamic interactions of the microbial cells with 
surfaces by altering the substratum effects. 
 
Hydrodynamics 
         Biofilms have also been examined under various 
hydrodynamic conditions such as laminar and 
turbulent flow.  It is found that biofilm response is altered 
in flow conditions. Biofilms  grown under laminar  flow  
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are  found to  be  patchy  and consist  of rough cell  
aggregates  separated by  interstitial  voids. Biofilms  
grown under  turbulent  flow  cells  are  also patchy  but  
are  elongated  “streamers” that  oscillate in the  bulk  
fluid. Association of cells with the surface also depends 
on cell size and cell motility.  
 
Characteristics of Aqueous Medium  
          Physico-chemical characteristics  of 
 aqueous  medium  such as  pH, 
nutrient  levels, ionic  strength and temperature,  etc. 
may  play  an important  role  in the rate  of  microbial  
attachment  to the  surfaces. The bacterial attachment 
and biofilm formation in different aqueous 
systems are affected by season. This may  be  due  to  
the  temperature  of  water  or  other seasonally  
affected parameters. It  is  found that  an increase  in 
concentration of  several  cations  such as sodium, 
calcium, lanthanum and ferric  ions  affects  the 
attachment  of P. fluorescence  by  reducing  the 
repulsive forces between the cell and glass surfaces. 
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Horizontal Gene Transfer   
   Horizontal  gene  transfer  is  important  for  the 
evolution and genetic  diversity  of  natural  microbial 
communities. During the evolution, and adaptation of 
bacteria  to new  environment  often results  in the 
acquisition of  new  genetic  traits  via  horizontal  gene 
transfer  rather  than accumulation  in  modification of 
gene  function by  mutations. The mobile genetic 
element mediates horizontal gene transfer  between 
bacteria. These elements can be conjugative plasmids, 
transposons or bacteriophages. Bacteria in biofilms 
expressing different phenotypic characters from 
planktonic counterparts. This is due to different genes 
transcribed in the planktonic and biofilm-associated 
phases of bacterial life cycle.  Some genes may be 
expressed in response to a specific surface on which 
bacterium has chosen to settle. Many marine Vibrio 
species survive by attachment and degradation to 
chitin. The  structural  genes  responsible  for 
attachment  to chitin differ from those  required for 
attachment  to abiotic, non-nutritive  surfaces  such as 
plastics  and glass. 
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Bacillus  subtilis strain harboring  conjugative  
transposons  which confers resistance to tetracycline 
was introduced to the system and resistance  profile  of  
biofilm  bacteria  was assessed. It was found that 
transfer of the conjugative transposons occurred within 
a biofilm resulting in Streptococcus species resistant to 
tetracycline. This was the first demonstration of gene 
transfer in an oral microbe growing in a biofilm and 
these findings indicate that non-oral bacteria have the 
potential to transfer genes to oral commensally. The 
transfer  of  TOL  plasmid, which carry  the  genes  for 
the degradation of toluene and the benzyl alcohol has 
occurred  in biofilm  community  growing  on benzyl 
alcohol  as  the  sole  carbon  and the  energy  source. 
Virus-mediated gene transduction is another mode of 
gene transfer in biofilm associated microbial 
community. 
 
Quorum Sensing  
 Cell   to  cell signaling has recently been 
demonstrated to play a role in cell attachment. 
Intracellular  communication between bacteria  is 
generally  carried out  by  bacterial  products  that  are 
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able  to diffuse  away  from  one  cell  and enter  into 
another  cell. This method of intracellular signaling 
seems ideally suited for bacteria in a diffusion-limited 
environment. Production of quorum sensing molecules 
is known as acyl-homoserine lactone (acyl-HSL). P. 
aeruginosa  mutants that  do not  produce  acyl-HSL  
form  biofilms  in which the cells are closely packed 
together and easily disrupted by  sodium  dodecyl  
sulfate. The role of intracellular signaling in multispecies 
biofilms significantly differ from that observed in single 
species biofilms. These signals are broadly classified as 
any actively or passively transmitted bacterial products 
that alter the state of neighboring microbes. These 
might include bacterial metabolites, acryl HSLs 
secreted proteins, genetic  material  such as  DNA  or 
RNA etc.,  This  signal  may  alter  distribution  of specific  
bacterial  species  in the  biofilm, alter  protein 
expression in neighboring  cells, introduce  new genetic  
trait  in neighboring  cells  and  incorporate bacteria  in 
biofilm. In addition to above  factors, properties  of  
cell  such as  cell  surface  hydrophilicity, presence  of  
fimbriae,  and  flagella  and production  of EPS 
influence  the  rate  and extent  of  attachment of 
microbial cells (Kokare C.R. et al., 2009). 
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Fig. 3: Mechanism of antimicrobial resistance 
 
The bacteria enclosed within the biofilm are 
extremely resistant to antibiotic treatments. Such 
resistance can be explained by hypotheses, not 
necessarily limited to the following ones. 
 
First, the EPS secreted by biofilm bacteria, acts as 
a physical/chemical barrier, thus preventing 
penetration by antibodies or many antibiotics. 
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Moreover, EPS is negatively charged and functions as 
an ion-exchange resin which is capable of binding a 
large number of the antibiotic molecules that are 
attempting to reach the embedded biofilm cells. 
 
Second, embedded biofilm bacteria are 
generally not actively engaged in cell division, are 
smaller in size and less permeable to antibiotics. Virtually 
all antimicrobials more effective in killing rapidly 
growing cells further  transition from exponential to 
slow/no growth is generally accompanied by 
expression of antibiotic-resistant factors. Slow growth 
activates the RelA-dependent synthesis of ppGpp, 
which inhibits anabolic processes in bacterial cells56. 
Interestingly, ppGpp suppressed the activity of a major 
E. coli autolysin, SLT57, which would make the cells 
more resistant to autolysis and could explain the 
mechanism of tolerance to antibiotics in slowly growing 
cells. ppGpp inhibits peptidoglycan synthesis, which 
would explain the decreased levels of activity of cell-
wall synthesis inhibitors under starvation conditions. 
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Third, antibiotic degrading enzymes such as β-
lactamase  may also be immobilized in the EPS matrix, 
so that the incoming antibiotic molecules can be 
inactivated effectively. It is interesting to note that 
biofilm cells of the P. aeruginosa have been shown to 
produce 32-fold more β-lactamase than cells of the 
same strain grown planktonically. 
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Fourth, up to 40% of the cell-wall protein 
composition of bacteria in biofilms is altered from 
Planktonic  cells .The membranes of biofilm bacteria 
might be better equipped to pump out antibiotics 
before they can cause damage, or even antibiotics 
targets may disappear.  
 
Fifth, the antimicrobial agent is deactivated in the 
outer layers of the biofilm, faster than it diffuses. This is 
true for reactive oxidants such as hypochlorite and 
Hydrogen peroxide. These antimicrobial oxidants are 
products of the oxidative burst of phagocytic cells and 
poor penetration of these may partially account for the 
inability of phagocytic cells to destroy biofilm 
microorganisms. 
 
Sixth, Biofilms also provide an ideal for the 
exchange of extrachromosomal DNA responsible for 
antibiotic resistance, Virulence factors and 
environmental survival capabilities at accelerated 
rates, making it a prefect milieu for emergence of drug 
resistance pathogens (PrakashB. et al., 2003). 
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Biofilm Examination and Measurement 
  Over the past years, several assays for biofilm 
quantification in microtiter plates have been described. 
These can be classified into biofilm biomass assays 
(based on the quantification of matrix and both living 
and dead cells), viability assays (based on the 
quantification of viable cells) and matrix quantification 
assays (based on the specific staining of matrix 
components). 
 Crystal violet (CV) staining was first described by 
Christensen G.D et al., (1985) and has since then been 
modified to increase its accuracy and to allow biofilm 
biomass quantification in the entire well. CV is a basic 
dye, which binds to negatively charged surface 
molecules and polysaccharides in the extracellular 
matrix. Because cells (both living and dead), as well as 
matrix are stained by CV, it is poorly suited to evaluate 
killing of biofilm cells. 
  
 The fluorogenic dye Syto9 is a nucleic acid stain, 
which diffuses passively through cellular membranes 
and binds to DNA of both viable and dead cells. As 
DNA is also a substantial part of the extracellular matrix, 
 37 
this staining will provide information on total biofilm 
biomass. Syto9 has previously been used in Confocal 
Laser Scanning Microscopy (CLSM) studies of biofilm 
composition and morphology. This stain has also been 
used for the routine quantification of bacterial and 
yeast biofilm biomass. 
 
To discriminate between living and dead cells, 
quantification techniques based on the metabolic 
activity of viable cells are available. Various viability 
stains involve the use of Tetrazolium salts, including 5-
Cyano-2, 3-ditolyl Tetrazolium Chloride (CTC) and 2, 3-
bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) 
carbonyl]- 2H-tetrazolium hydroxide (XTT) The XTT assay 
is based on the reduction of the XTT dye to a water-
soluble formazan. The absorbance of the cell 
supernatant is proportional to the number of 
metabolically active microbial cells. The XTT assay has 
been used extensively for the quantification of viable 
cells in Planktonic cultures and for the quantification of 
bacterial and yeast biofilms. Despite its popularity, 
problems regarding intra- and interspecies variability 
have been reported.  Another viability assay is based 
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on the reduction of Resazurin by metabolically active 
cells. This is a blue compound that can be reduced to 
pink resorufin, which is fluorescent. Although this dye, 
also known as Alamar Blue, is mainly used in viability 
assays for mammalian cells, it has also been applied 
extensively in susceptibility testing of fungi, 
Mycobacterium tuberculosis, Staphylococcus 
epidermidis and Streptococcus mutans. Viable 
microbial cells are also capable of converting non 
coloured non-fluorescent Fluorescein Di Acetate (FDA) 
into yellow, highly fluorescent fluorescein by non-
specific intra and extracellular esterases. FDA has been 
used for measuring total microbial activity in soil and 
litter, as well as for the quantification of biofilm biomass.  
 
The quantification of the biofilm matrix, an 
essential component of the biofilm, is also of interest. 
The dye 1,9-DiMethyl Methylene Blue (DMMB), originally 
applied for quantification of sulphated 
glycosaminoglycans in chondrocyt cultures has also 
been used to quantify Staphylococcus aureus biofilm 
matrices. DMMB forms an insoluble complexation 
product with sulphated polysaccharides in the biofilm 
matrix. The amount of dye released by adding a 
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decomplexation solution is spectrophotometrically 
measured and reflects the amount of sulphated 
polysaccharides present in the biofilm matrix (Peeters E., 
et al., 2008 and Pettit K.R et al., 2005). 
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REVIEW OF LITERATURE 
 
 
Eftekhar F. et al., 2009 evaluated biofilm production by 
Staphylococcus epidermidis isolates, from nosocomial infections 
and skin of healthy volunteers. In this work, biofilm phenotype and 
icaADBC gene carriage were studied in 50 S. epidermidis isolates. 
Biofilm phenotype was studied by colony morphology on Congo 
red agar and the Microtiter plate method. Polymerase chain 
reaction was   employed to detect the presence of icaADBC 
operon. The results showed no significant difference between the 
two groups of isolates for the potential to form biofilms by the two 
phenotypic assays, produced by the two groups. On the other hand, 
ica gene carriage was more discriminatory and was observed in 
30% of group A isolates compared to group B of 8% of the skin 
isolates. 
 
Barbara V.U. et al., 2009 evaluated the role of bacterial 
extracellular polysaccharides in biofilm. Extracellular polymeric 
substances (EPS) produced by microorganisms are a complex 
mixture of biopolymers primarily consisting of polysaccharides, as 
well as proteins, nucleic acids, lipids and humic substances. EPS 
make up the intercellular space of microbial aggregates and form 
the structure and architecture of the biofilm matrix. The results 
showed, the key functions of EPS comprise the mediation of the 
initial attachment of cells to different substrata and protection 
against environmental stress and dehydration. 
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Kokare C.R et al., 2009 reviewed the importance and 
application of biofilm. In this review authors were discussed the 
formation of biofilm, structure, role in microbial communities and 
its application in detailed manner. 
 
Juda.M et al., 2008 reported EDTA as a potential agent in 
preventing formation of Staphylococcus epidermidis biofilm on 
polychloride vinyl biomaterials.  The 6 strains of S. epidermidis 
was found that were able to form the biofilm on PCV biomaterials, 
but irrespective of adhesion properties. The results showed 
bacteriostatic effect of EDTA against planktonic cells of the 
isolates in the concentration of 0.25–0.5mmol/l (MIC). The 
adhesion process and formation of the biofilm was inhibited by 
EDTA at concentrations of 1.0–2.0mmol/l. The eradication of the 
mature biofilm was achieved at 2.0–4.0mmol/l EDTA for two 
strains, while for the other four isolates, concentration of EDTA 
needed for eradication effect was greater 32 mmol/l. 
 
Hardy M.T. et al., 2008 examined invitro activity of 
antibiotic combinations against Pseudomonas aeruginosa biofilm 
and planktonic cultures. Micronized Tobramycin, Clarithromycin, 
Azithromycin, PolymyxinB, Colistin, Polylysin, Protamine and 
Chitosan were used. Among the antibacterial agents tested, 
Tobramycin and PolymyxinB had the strongest activity against 
planktonic cultures when tested alone. Synergistic activity was 
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observed for the combination chitosan/Tobramycin against 
planktonic cultures but not biofilms, and for the combination 
Tobramycin/Clarithromycin against biofilms but not planktonic 
cultures. Their results suggest that the combination of 
Clarithromycin/Tobramycin may be successful for eradicating 
infections involving bacterial biofilms by   P. aeruginosa. 
 
Mehdi H. et al., 2008 reported on the investigation of alkane 
biodegradation using the microtiter plate method and correlated. 
The strain BC (Pseudomonas) could remove crude oil by 83%, and 
produces more biosurfactant, and its biofilm formation is higher 
compared to other strains. Bacterial adhesions to crude oil for other 
strains CS-2 (Pseudomonas), BC, PG-5 (Rhodococcus) and H 
(Bacillus) were 30%, 46%, 10% and 1%, respectively. PCR 
analysis of these four strains showed that all isolates had alk-B 
genes. 
 
Naves P. et al., 2008 studied correlation between virulence 
factors and  invitro biofilm formation by Escherichia coli strains. 
The ability of 15 Escherichia coli strains to form biofilms on 
polystyrene plates was studied. Virulence factors-associated genes 
30 were analyzed, including 15 adhesions (papC, papG and its 
three alleles, sfa/focDE, sfaS, focG, afa/draBC, iha, bmaE, gafD, 
nfaE, fimH, fimAvMT78, agn43, F9 fimbriae and type 3 fimbriae-
encoding gene clusters), four toxins (hlyA, cnf1, sat and tsh), four 
siderophore (iron, fyuA, iutA and iucD), five proctetins/invasion-
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encoding genes (kpsM II, kpsMT III, K1 kps variant- neuC, traT 
and ibeA), and the pathogencity island malX and cvaC. Their 
results showed that seven strains were classified as strong biofilm 
producers and the remaining eight strains were regarded as weak 
biofilm producers. 
 
Peeters E. et al., 2008 compared the multiple methods for 
quantification of microbial biofilms grown in microtiter plates. In 
this study six assays for the quantification of biofilms formed in 
96-well microtiter plates were optimized and evaluated, the crystal 
violet  assay, the Syto9 assay, the fluorescein diacetate  assay, the 
resazurin assay, the XTT assay and the DiMethyl Methylene Blue 
assay. Their data showed that some assays are less suitable for the 
quantification of biofilms of particular isolates.   
 
Guillot P.V. et al., 2007 reported   in-vitro activities of 
different inhibitors of bacterial transcription against 
Staphylococcus epidermidis biofilm. Only a few antibacterial 
agents were relatively active against biofilm. Among the 
transcription inhibitors Rifampin, was the most effective molecule 
against biofilm-related infections. 
 
Burton E. et al., 2007 studied microplate 
spectrofluorometric assay for bacterial biofilms. The method 
involved staining of biofilms and the fluorescence of stained 
biofilms was measured with a fluorescent plate reader. This 
method was compared with a widely used microplate colorimetric 
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assay involving crystal violet staining. A strong linear association 
existed between the two methods (r 2=0.99/0.94). Being more 
sensitive and specific as compared to colorimetric method, the 
spectrofluorometric assay provides a better alternative for 
quantification and characterization of bacterial biofilms. 
 
Sung B.H. et al., 2006 developed a biofilm production-
deficient Escherichia coli strain as a host for biotechnological 
applications. Bacteria form biofilms by adhering to biotic or abiotic 
surfaces. This phenomenon causes several problems. To overcome 
the the problems associated with biofilm, the authors  created a 
biofilm production-deficient Escherichia coli strain, BD123, by 
deleting genes involved in curli biosynthesis and assembly, (csgG-
csgC) colanic acid biosynthesis and assembly,(wcaL-wza) and type 
I pilus biosynthesis,(fimB-fimH). E. coli BD123 remained mostly in 
the form of planktonic cells and became more sensitive to the 
antibiotics Streptomycin and Rifampin than the wild-type E. coli 
MG1655: the growth of BD123 was inhibited by one-fourth of the 
concentrations needed to inhibit MG1655. 
 
Mathur T. et al., 2006 detected the biofilm formation 
among the clinical isolates of Staphylococci using three different 
screening methods. Staphylococcus spp(152) 88(57.8%) displayed 
a biofilm-positive phenotype under the optimized conditions in the 
Tissue Culture Plate(TCP) method and strains were further 
classified as high 22 (14.47 %) and moderate 60 (39.4 %) while in 
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70 (46.0 %) isolates weak or no biofilm was detected. Though 
Tube Method(TM) correlated well with the TCP test for 18 (11.8 
%) strongly biofilm producing strains, weak producers were 
difficult to discriminate from biofilm negative isolates. Screening 
on Congo Red Agar (CRA) does not correlate well with either of 
the two methods for detecting biofilm formation in Staphylococci.  
The TCP method was found to be most sensitive, accurate and 
reproducible screening method for detection of biofilm formation 
by Staphylococci.  
 
Hola V. et al., 2006 studied the dynamics of Staphylococcus 
epidermis biofilm formation in relation to nutrition, temperature 
and time. In this study the dynamics of biofilm formation was 
correlated with nutrition and temperature conditions during the 
cultivation of biofilm-positive Staphylococcus epidermidis isolates. 
The cultivation was performed on standard microtiter plates and 
the wells were examined for the production of biofilm every 1 up 
to 48 hrs. All the tested strains showed better growth of the biofilm 
at a temperature of 37 °C in a nutrient-richer environment. The first 
signs of bacterial adhesion were visible after 2–4 hrs but a very 
thin layer was visible after 5 hours, after 10 hrs the biofilm layer 
seemed to be mature – the changes in thickness were not so evident 
after this time. After cultivation longer than 34–42 hrs, parts of the 
biofilm layer started to detach, and consequently the biofilm 
became non-homogeneous. Their result suggests that for biofilm 
cultivation 12–16 hrs should be sufficient. 
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Merritt J.H. et al., 2005 reported four basic protocols for 
the growth and analysis of biofilms in static systems. The 
microtiter plate biofilm assay was a useful method for assessing 
bacterial attachment by measuring the staining of the adherent 
biomass. The air-liquid interface assay was complementary to the 
microtiter plate biofilm assay in that it provides a mechanism for 
direct microscopic viewing of the live attached microbes. A 
colony-based biofilm system is also described with this system 
being especially useful for monitoring cell death in biofilms treated 
with antimicrobial agents. Kadouri Drip-Fed Biofilm Assay growth 
can be maintained for a much longer period, allowing formation of 
mature biofilms. 
 
Cerca N. et al., 2005 studied quantitative analysis of 
adhesion and biofilm formation on hydrophilic and hydrophobic 
surfaces of clinical isolates of Staphylococcus epidermidis.  The 
major virulence factor of these organisms is their ability to adhere 
to devices and form biofilms. In this study, the initial adhesion to 
different materials (acrylic and glass) of 9 clinical isolates of S. 
epidermidis, along with biofilm-positive and biofilm-negative 
control strains, was assayed using physico-chemical interactions to 
analyze the basis for bacterial adherence to the substratum. X-ray 
photo electron spectroscopy (XPS) analysis of the cell surface 
elemental composition was also performed in an attempt to find a 
relationship between chemical composition and adhesion 
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capabilities. Biofilm formation on the two surfaces was evaluated 
by dry weight measurements. The clinical isolates exhibited 
different cell wall physico-chemical properties, resulting in 
differing abilities to adhere to surfaces. Adhesion to hydrophobic 
substrata for all strains occurred to a greater extent than that to 
hydrophilic surfaces. However, no direct relationship was found 
between the amount of biofilm formed and the initial adhesion 
extent. These results indicate that high levels of initial adherence 
do not necessarily lead to thick biofilm formation. These two 
aspects of the pathogenesis of medical device related-infection may 
need to be evaluated independently to ascertain the contribution of 
each to the virulence of S.epidermidis causing device-related 
infections. 
 
Fux C.A. et al., 2005 Studied survival strategies of 
infectious biofilms. Bacterial biofilms are difficult to detect in 
routine diagnostics and are inherently tolerant to host defenses and 
antibiotic therapies. The authors reviewed current concepts of 
biofilm tolerance with special emphasis on the role of the biofilm 
matrix and the physiology of biofilm embedded cells. The 
heterogeneity in metabolic and reproductive activity within a 
biofilm correlates with a non-uniform susceptibility of enclosed 
bacteria. Nutritional starvation and high cell density, two key 
characteristics of biofilm physiology, also mediate antimicrobial 
tolerance in stationary-phase planktonic cultures. 
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Stepanovic et al., 2001studied the modified microtiter plate   
tests to investigate biofilm formation by Staphylococci under both 
static and dynamic conditions. The quantity of biofilm produced 
under static conditions was used as are reference. Dynamic 
conditions were achieved by incubating microtiter plates on a 
horizontal shaker. Dynamic conditions particularly affected the 
capacity of certain species to produce biofilm. These species 
included the causative agents of infections associated with a 
foreign body (Staphylococcus epidermidis, Staphylococcus aureus- 
ATCC 25923).  Their results revealed that, dynamic conditions 
should be included as a parameter for evaluating biofilm formation 
by Staphylococci in vitro. 
 
Spoering A.L. et al., 2001 compared the tolerance level of 
biofilms versus stationary- and logarithmic-phase planktonic cells 
of Pseudomonas aeruginosa with four different antimicrobial 
agents. In general, stationary-phase cells were somewhat more 
tolerant than biofilms in all of the cases examined.  They 
concluded that, at least for Pseudomonas aeruginosa, one of the 
model organisms for biofilm studies, the notion that biofilms have 
greater resistance than do planktonic cells is unwarranted. They 
further suggest that tolerance to antibiotics in stationary-phase or 
biofilm cultures is largely dependent on the presence of persister 
cells. 
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Ashby M.J. et al., 1994 reported effect of antibiotics on 
non-growing planktonic cells and biofilms of Escherichia coli. 
Several classes of antibiotics were assessed for activity against 
non-growing Escherichia coli and cells grown as a biofilm. 
Antibiotics which had activity against non-growing cells also 
showed some activity against biofilms. The most effective 
antibiotics were Imipenem and Ciprofloxacin, which were also 
active against steady state biofilms. Their results suggest that 
growth rate plays a   major role in mediating resistance of biofilms 
to antibiotics. 
 
Drancourt M. et al., 1993 reported oral Rifampin plus 
Ofloxacin for treatment of Staphylococcus-infected orthopedic 
implants. The authors were examined the effectiveness and safety 
of the combination of Rifampin plus Ofloxacin given orally for 
treating prosthetic orthopedic implants infected with Staphylococci. 
The combination of Rifampin administered orally plus Ofloxacin is 
a suitable alternative to the conventional long-term intravenous 
therapy for treatment of orthopedic implants infected with 
Staphylococci. 
 
Gallimore B. et al., 1991 reported natural history of chronic 
Staphylococcus epidermidis foreign body infection in a mouse 
model. The development and characterization of a mouse model of 
chronic Staphylococcus epidermidis foreign body infection was 
done with two clinical isolates that differed in degree of 
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extracellular slime production. Both test strains of S. epidermidis 
persisted at the implant site through the 6-month follow-up in 80% 
of the mice, regardless of the degree of slime production. There 
was no evidence of overt animal morbidity, and microbiologic 
assessment of other peritoneal sites did not reveal dissemination of 
bacteria from the infected focus. In comparison with control mice, 
animals harboring chronic foreign body infection presented marked 
neutrophilia and mild anemia. 
 
Prosser, B.T., et al., 1987 evaluated effects of antibiotics on 
bacterial biofilm.   Antibiotics are generally not effective against 
biofilms. A simple method of studying the effect of antibiotics on 
Escherichia coli ATCC 25922 biofilms was established on 0.5 cm2 
catheter disks. The disks were incubated for 1 h at 37°C, washed, 
transferred to petri dishes containing 20 ml of broth, and incubated 
at 37°C for 20 to 22 h, at which time thick biofilms were 
established. Disks were washed, placed in broth or broth containing 
antibiotic, and incubated at 37°C for 4 h. The disks were removed, 
and viable counts were determined. Viable bacterial counts 
decreased from 103 to 104 CFU/cm2 in 24 h with 400 mcg of 
Amdinocillin or Cefamandole per ml. A combination containing 
400mcg of each antibiotic per ml decreased the viable counts to an 
undetectable level (<100 CFU/ cm2) in 24 hrs. 
 
Christensen, G.D. et al., 1982 studied the adherence of 
slime-producing strains of Staphylococcus epidermidis to smooth 
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surfaces. Slime production is not a generally recognized feature of 
Staphylococcus epidermidis. Through the results suggest that slime 
mediated adherence may be a critical factor in the pathogenesis of 
S.epidermidis infections.  
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MATERIALS 
 
APPARATUS’ USED 
Centrifuge tubes   - Eppendorf 
Glasspipettes   - Borosil 
Micropipettes   - Vari pippets 
Petriplates    - Borosil  
Standard flask   - Borosil 
Sterile swabs   - Hi media 
Test tubes     -  Borosil 
Tissue Culture Plate  - Tarsons 
CHEMICALS USED  
Acetic acid    -
 Qualigens,Mumbai. 
Acetone     - Qualigens,Mumbai. 
Agar Agartype 1   -  Hi media labs ltd, 
Mumbai. 
Ammonium sulphate  - S.d fine chemicals ltd,  
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Mumbai. 
Congo Red    -  Hi media labs ltd, 
Mumbai. 
Crystal Violet   -  Qualigens, Mumbai. 
Disodium hydrogen  
Phosphate    -   S.d fine chemicals 
ltd,  
Mumbai. 
Ethanol    -  Qualigens, Mumbai. 
Glucose    -  Qualigens,Mumbai. 
 Mannitol salt agar   - Hi media labs ltd, 
Mumbai.           
 Mannitol salt broth  -  Hi media labs ltd, 
Mumbai. 
Methanol    -  Qualigens, Mumbai. 
Mueller Hinton Agar  -  Hi media labs ltd, 
Mumbai. 
Mueller Hinton Broth  -  Hi media labs ltd, 
Mumbai. 
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Non absorbent cotton   - Ramraju surgical 
cotton Ltd  
Rajapalayam. 
Sodium chloride   -  
Qualigens,Mumbai 
Sodium Dihydrogen  
Phosphate -  S.d fine chemicals Ltd  
Mumbai 
Sucrose    -  Qualigens,Mumbai. 
Tetrazolium salt   -  Hi media labs ltd, 
Mumbai. 
Trypticase soy broth  - Hi media labs ltd, 
Mumbai. 
INSTRUMENTS USED 
Alpha digitoc   - Technico 
Autoclave   - Universal Autoclave 
Centrifuge    - Eppendorf 
Digital balance   - Shimadzu 
Heating mantle   - Guna enterpirses 
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Hot air oven    - Technico  
Incubator    - Technico 
Microscope    - Motic 
UV-Spectrophotometry  - Shimadzu 
Vertical laminar flow hood - Technico 
DRUGS USED 
Ofloxocin  - Pure sample gift from SKN Organics 
Laboratories Pvt. 
Ltd Chennai.  
 
Rifampin   - Pure sample gift from SKN Organics 
Laboratories Pvt.  
Ltd Chennai.                                 
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METHODOLOGY 
 
Microorganisms Used 
The reference strain used in the study was 
Staphylococcus aureus ATCC25923 (Stepanovic et al., 
2001) which was obtained from NCIM, Pune. One 
Clinical isolate Staphylococcus aureus and two 
Staphylococcus epidermidis were obtained from the 
Dept. of Microbiology, Sri Ramakrishna Hospital, 
Coimbatore. The strains were represented as S-I, S-II, S-III 
and S-IV.  
 
Maintenance of culture 
        The selected strains were confirmed for their purity 
and identity by Grams staining method and by their 
characteristic biochemical reactions like catalase and 
coagulase test (Mackie and McCartney 14th edition 
1996). The selected strains were preserved by 
subculturing them periodically on Nutrient agar slants 
and storing them under frozen condition. For the study 
fresh 24 hrs broth cultures were used.   
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 Standardization of inoculum 
 All organisms were grown overnight (24 hrs) at 37o 
C on Nutrient Agar (NA) and harvested during the 
stationary growth phase. Active cultures for 
experiments were prepared by transferring a loopful of 
cells from the stock cultures to test tubes of Mueller-
Hinton broth 24 hrs at 37°C. Inoculum was standardized 
by matching the turbidity of the culture to 0.5 
McFarland standard. This was produced by mixing 0.5ml 
of 0.048 M Bacl2 (1.175% w/v Barium Chloride 
dehydrates) with 99.5 ml of   0.36 N H2SO4.) This 
produced an inoculating suspension of approximately 
2.0×106 (CFU/ml) for bacteria. 
 
A. IDENTIFICATION OF BIOFILMS 
             The ability of all the four strains to form biofilm 
was assessed by the following,  
 
(i) Tissue Culture Plate (TCP) Method  
Procedure 
The Staphylococcus isolates were inoculated into 
3-5ml of Trypticase soy broth supplemented 
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with1%glucose (TSB) and grown to stationary phase. The 
culture was diluted 1:100 in the same media. Individual 
wells of sterile polystyrene 96 well tissue culture plates 
were filled with 0.2 ml aliquots of the diluted cultures 
with broth alone serve as control. After inoculation the 
tissue culture plates were covered and incubated for 
48-72 hrs at 37°C. After incubation content of each well 
was gently removed by tapping the plates. The wells 
were washed three-four times with 0.2 ml of phosphate 
buffer saline (PBS) pH 7.4 to remove free-floating 
‘planktonic’ bacteria. 
 
The biofilms formed by adherent ‘sessile’ 
organisms were stained with Crystal Violet (0.7 % w/v). 
Excess stain was rinsed off by thorough washing with 
deionized water and plates were kept for drying. 
Adherent cells formed biofilm on all sides of the well 
and were uniformly stained by Crystal Violet. 
 
 
(ii) Tube Method  
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In Tube method TSB (2ml) was inoculated with 
loopful of microorganism from overnight culture plates 
and incubated for 48-72 hrs at 37°C. The tubes were 
decanted and washed with PBS and dried. Dried tubes 
were stained with crystal violet (0.7%). Excess stain was 
removed and tubes were washed with deionized 
water. Tubes were than dried in inverted position and 
observed for biofilm formation. 
 
Biofilm formation was considered positive when a 
visible film lined the wall and bottom of the tube. Ring 
formation at the liquid interface was not indicative of 
biofilm formation. Tubes were examined and the 
amount of biofilm formation was scored as 0-absent, 1-
weak, 2-moderate and 3-was considered as strong. The 
experiment  was performed in triplicate and repeated 
three times. 
 
(iii) Congo Red Agar (CRA) Method  
The composition of   Congo red agar media is 
given below: 
Brain Heart Infusion broth - (37 gms/L) 
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Sucrose - (50 gms/L) 
Agar No.1 - (10 gms/L)  
Congo Red Stain-(0.8 gms/L). 
 
Congo Red was prepared as concentrated 
aqueous solution and autoclaved at 121°C for 15 
minutes, separately from other medium constituents 
and was then added when the agar had cooled to 
55°C. Plates were inoculated with Staphylococcus 
isolates and incubated aerobically for 24 -48 hrs   at 
37°C. 
 
Positive result is indicated by black colonies with a 
dry crystalline consistency. Weak slime producers 
usually remained pink, though occasional darkening at 
the centers of colonies was observed. A darkening of 
the colonies with the absence of a dry crystalline 
colonial morphology indicated an indeterminate result. 
The experiment was performed in triplicate and 
repeated three times (Mathur T. et al., 2006 and 
Freeman D.J., et al., 1989). 
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B. DETERMINATION OF ADHESION TO THE BIOMATERIAL 
in-vitro BY TTC (2, 3, 5 –TRIPHENYL TETRAZOLIUM 
CHLORIDE) METHOD 
The ability of adhesion of the Staphylococcus 
isolates on biomaterial (catheter) was studied in-vitro by 
TTC method. It’s based on the ability of living cells to 
reduce tetrazolium salt to red formazan Precipitate 
(Gallimore et al., 1991). The standardized bacterial 
suspensions (according to 0.5 McFarland standard) in 
sterile PBS were incubated with appropriate biomaterial 
for 1, 2, 4, 8, 12, 24, 48 and 72 hrs at 37°C. Non adherent 
cells were removed by careful rinsing of catheter 
fragment with sterile PBS and then resuspended in TSB 
medium with one drop of 1% TTC, followed by overnight 
incubation at 37°C. The minimal time needed for 
adhesion process was determined visually by an 
appearance of red formazan precipitate, on the 
biomaterial surface (catheter) and in the medium. 
 
C. DETERMINATION OF BIOFILM FORMATION ON THE 
BIOMATERIAL in-vitro BY TTC METHOD 
  The ability of formation of biofilm by the 
Staphylococcus isolates on biomaterial (catheter) was 
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studied in-vitro also by TTC method (Gallimore et al., 
1991). The standardized bacterial suspensions 
(according to 0.5McFarland standard) in TSB were 
incubated with appropriate biomaterial for 24 hrs at 
37°C. Nonadherent cells were removed by careful 
rinsing of catheter fragment with sterile PBS and then 
resuspended in fresh TSB. Medium changing and 
catheter washing procedures after overnight 
incubation at 37°C were repeated three-five times. 
Finally, one drop of 1% TTC solution was added, 
followed by overnight incubation at 37°C. Biofilm 
formation was determined visually on the basis of an 
appearance of red formazan precipitate both on the 
catheter surface and in the medium (Juda M. et al., 
2008). 
 
D. QUANTIFICATION OF BIOFILM BY CRYSTAL VIOLET 
METHOD 
Stock solution of 0.1%Crystal Violet was prepared 
by using 33%w/v Acetic acid. From the stock solution, 
different concentrations in the range of 0.5 to 10μg/ml 
were prepared. Absorbance was measured at 570nm; 
using 33% w/v acetic acid was used as blank. 
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After biofilm formation on biomaterial in different 
hrs, it was thoroughly washed with PBS then placed in 
room temperature for one hour. The biomaterial was 
stained with Crystal Violet for 30 minutes. 10ml of 33% 
w/v Acetic acid  was used to extract the stained 
Crystal Violet and absorbance was measured at 570nm 
using 33% Acetic acid as blank (Merritt J.H.et al 2005). 
 
E. DETERMINATION OF MINIMAL INHIBITORY 
CONCENTRATION (MIC) OF OFLOXACIN AND RIFAMPIN   
The MIC was performed by the broth dilution 
method. The 2-fold serial dilutions of the antimicrobial 
agents were made from the concentrations of 
Ofloxacin ranged from (500-0.24 µg/ml) and Rifampin 
(50 - 0.02 µg/ml). All tubes were inoculated with 50 μl 
volume of bacterial culture, which contains 105 CFU/ml. 
They were incubated overnight (18 to 24 hrs) at 37°C 
and examined for growth indicated by turbidity MICs 
were recorded as the lowest drug concentrations that 
completely inhibited visible growth of bacteria. Positive 
and negative controls were also kept for comparisons. 
The determinations of MICs were performed in 
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triplicates for each organism and the experiment was 
repeated where necessary. 
 
F. DETERMINATION OF MINIMAL BACTERICIDAL 
CONCENTRATION (MBC) OF OFLOXACIN AND RIFAMPIN   
The MBC was performed by the streak plate 
method. After MIC determination, a loopful of broth 
was collected from those tubes which did not show any 
growth and inoculated on sterile Trypticase Soy Agar by 
streaking. Test organisms to serve as control. 
 
 
          Plates were then incubated at 37°C for 24 hrs. 
After incubation the concentration at which no visible 
growth was seen was noted as the minimal bactericidal 
concentration (Victor Lorian 3rd edition 96-100). 
 
G. THE EFFECT OF OFLOXACIN AND RIFAMPIN ON 
ADHESION TO BIOMATERIAL in- vitro BY TTC METHOD  
   In order to assay the effect of Ofloxacin and 
Rifampin on adhesion, the standardized bacterial 
suspensions (according to 0.5 McFarland standard) in 
sterile PBS containing Ofloxacin (500-0.24µg/ml) and 
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Rifampin (50-0.02µg/ml) were incubated with 
appropriate biomaterial for 12–48 hrs (according to the 
minimal time needed for adhesion of each strain to 
biomaterial) at 37°C. Then, a drop of 1% TTC solution 
was added, followed by overnight incubation at 37°C. 
The minimal concentration of Ofloxacin and Rifampin 
inhibited adhesion process was determined visually as 
the concentration where the red formazan precipitate 
was notfound, neither on the catheter surface nor in 
the medium. 
 
H. THE EFFECT OF OFLOXACIN AND RIFAMPIN ON 
BIOFILM FORMATION ON BIOMATERIAL in-vitro BY TTC 
METHOD 
In order to assay the effect of Ofloxacin and 
Rifampin  on biofilm formation, the bacterial 
suspensions in TSB containing Ofloxacin (500-0.24µg/ml) 
and Rifampin (50-0.02µg/ml)were incubated with 
appropriate biomaterial for 72 and 96 hrs at 37°C, with 
medium changing and catheter washing process as 
described above. Then, a drop of 1% TTC solution was 
added, by overnight incubation at 37°C. The minimal 
concentration of Ofloxacin and Rifampin that inhibited 
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biofilm formation was determined visually as the 
concentration where the red formazan precipitate was 
not found neither on the catheter surface nor in the 
medium. 
 
I. THE EFFECT OF OFLOXACIN AND RIFAMPIN ON MATURE 
BIOFILM ON BIOMATERIAL in- vitro BY TTC METHOD 
           In order to assay the effect of Ofloxacin (500-
0.24µg/ml) and                                        Rifampin  (50-
0.02µg/ml) on biofilm eradication, the mature biofilm 
was incubated in the presence of  Ofloxacin and 
Rifampin   for 24 hrs and then a drop of 1% TTC solution 
was added, followed by overnight incubation at 37°C. 
The minimal concentration of Ofloxacin and Rifampin  
eradicated the mature biofilm, determined visually as 
the concentration, at which the red formazan 
precipitate was not found, neither on the catheter 
surface nor in the medium (Juda M et al., 2008). 
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Fig.7:  In-vitro determination of adhesion 
on biomaterial by TTC method 
 
 
Red Formazan precipitate of TTC indicates adhesion of  
S-I on biomaterial.           
          
        Table No 4: Adhesion duration of S-I on biomaterial  
  
 
 
 
 
The red 
formazan 
S.No Duration in hrs 
Appearance of Red  
Formazan precipitate 
1 1 - 
2 2 - 
3 4 - 
4 8 - 
5 12 Present 
6 24 Present 
24h          12h           8h            4h          2h        
1h     
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precipitate appeared on the biomaterial after 12 hrs incubation at 37°C 
indicating the minimal time needed for adhesion in S-I strain to be 12 hrs. 
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Fig.8: In-vitro determination of adhesion 
on biomaterial  by TTC method 
 
 
Red Formazan precipitate of TTC indicates adhesion of 
S-II on biomaterial 
 
Table No 5: Adhesion duration of S-II on biomaterial     
S.No Duration in hrs 
Appearance of Red 
 Formazan precipitate 
1 1 - 
2 2 - 
3 4 - 
4 8 - 
5 12 - 
6 24 Present 
7 48 Present 
 
  48h      24h    12h      8h     4h      2h      
1h     
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The red formazan precipitate appeared on the biomaterial after 
24hrs incubation at 37°C indicating the minimal time needed for adhesion in S –II 
strain to be 24hrs. 
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Fig.9: In- vitro determination of adhesion 
on biomaterial by TTC method 
 
 
Red Formazan precipitate of TTC indicates adhesion of 
S-III on biomaterial 
 
Table No 6: Adhesion duration of S-III on biomaterial    
S.No Duration in hrs 
Appearance of Red  
Formazan precipitate 
1 1 - 
2 2 - 
3 4 - 
4 8 - 
5 12 - 
6 24 Present 
 48h     24h      12h        8h         4h      2h       
1h     
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The red 
formazan 
precipitate appeared on the biomaterial after 24hrs incubation at 37°C 
indicating the minimal time needed for adhesion in S –III strain to be 24hrs. 
 
 
Fig.10: In- vitro determination of adhesion 
on biomaterial by TTC method 
 
 
Red Formazan precipitate of TTC indicates adhesion of  
S-IV on biomaterial 
 
   TableNo7: Adhesion duration of S-IV on biomaterial 
S.No Duration in hrs 
Appearance of Red  
Formazan precipitate 
7 48 Present 
  72h     48h     24h      12h      8h      4h       
2h   1h     
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1 1 - 
2 2 - 
3 4 - 
4 8 - 
5 12 - 
6 24 - 
7 48 Present 
8 72 Present 
 
The red formazan precipitate appeared on the biomaterial after 
48hrs incubation at 37°C indicating the minimal time needed for adhesion in S –IV 
strain to be 48hrs. 
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Fig.11: In- vitro determination of biofilm formation 
on biomaterial by TTC method 
 
 
Red Formazan precipitate of TTC indicates biofilm formation of   
S-I on biomaterial 
 
Table No 8: Biofilm formation duration of S-I on biomaterial 
S.No Duration in hrs Appearance of Red Formazan precipitate 
1 24 - 
2 48 - 
3 72 Present 
4 96 Present 
The red formazan precipitate appeared on the biomaterial after 
72hrs incubation at 37°C indicating the minimal time needed for biofilm 
formation by   S-I  strain to be 72hrs. 
        96h      72h       48h         24 
h             
 75 
Fig.12: In- vitro determination of biofilm formation  
 on biomaterial by TTC method 
 
 
Red Formazan precipitates of TTC indicates biofilm formation of  
S-II on biomaterial 
Table No 9: Biofilm formation duration of S-II on biomaterial  
S. No Duration in hrs 
Appearance of Red 
 Formazan precipitate 
1 24 - 
2 48 - 
3 72 Present 
4 96 Present 
 
The red formazan precipitate appeared on the biomaterial after 
72hrs incubation at 37°C indicating the minimal time needed for biofilm 
formation by S-II  strain to be 72hrs. 
 96h            72h            48h         
24 h             
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Fig.13: In- vitro determination of biofilm formation on biomaterial 
by TTC method 
 
 
 
 
       Red Formazan precipitate of TTC indicates biofilm formation of  
       S-III on biomaterial 
 
Table No10: Biofilm formation duration of S-III on biomaterial 
S. No Duration in hrs 
Appearance of Red  
Formazan precipitate 
1 24 - 
2 48 - 
3 72 Present 
4 96 Present 
 
 96h               72h              48h           
24 h             
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The red formazan precipitate appeared on the biomaterial after 
72hrs incubation at 37°C indicating the minimal time needed for biofilm 
formation by S-III  strain to be 72hrs. 
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Fig.14: In- vitro determination of biofilm formation on 
 biomaterial by TTC method 
 
 
 
Red Formazan precipitate of TTC by biofilm formation of 
S-IV on biomaterial 
 
Table No11: Biofilm formation duration of S-IV on biomaterial 
S. No Duration in hrs 
Appearance of Red  
Formazan precipitate 
1 24 - 
2 48 - 
3 72 - 
4 96 Present 
5 120 Present 
 
     120h        96h               72h              48h                24 
h 
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The red formazan precipitate appeared on the biomaterial after 
96hrs incubation at 37°C indicating the minimal time needed for biofilm 
formation by S-IV strain to be 96hrs. 
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QUANTIFICATION OF BIOFILM BY   
CRYSTAL VIOLET METHOD 
 
Table No12: Standard Graph for assay of crystal 
 Violet by Spectrophotometric method 
 
S. 
No 
Concentration 
μg/ml. 
Absorbance at 
570nm 
1 1 0.1467 
2 2 0.2872 
3 4 0.5989 
4 6 0.8866 
5 8 1.2057 
6 10 1.5531 
 
Graph No1: Standard Graph for Assay of Crystal Violet by 
Spectrophotometric Method 
Concentration of crystal violet 
A
bs
or
ba
nc
e 
a
t 5
70
nm
 
r = 0.999516 
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Table No13: Quantification of biofilm in S-I by  
Crystal Violet method  
S.  
No 
Time in  
hrs 
Absorbance at 
570nm 
Concentration of Crystal 
Violet µg/ml 
1 72 0.4697 3.17 
2 96 0.5205 3.50 
3 120 0.5783 3.87 
 
The concentration of Crystal Violet at different time interval was 
interpolated from the calibration graph (page no.53). The results were 
correlated with amount of biofilm formed. 
 
 
Table No14: Quantification of biofilm in S-II by  
Crystal Violet method 
 
S.  
No 
Time in hrs Absorbance at 570nm 
Concentration of  
Crystal Violet µg/ml 
1 72 0.4731 3.19 
2 96 0.5333 3.58 
3 120 0.5964 3.99 
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The concentration of Crystal Violet at different time interval was 
interpolated from the calibration graph (page no.53). The results were 
correlated with amount of biofilm formed. 
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Table No15: Quantification of biofilm in S-III by  
Crystal Violet method 
 
S.  
No 
Time in hrs Absorbance at 570nm 
Concentration of  
Crystal Violet µg/ml 
1 72 0.3886 2.63 
2 96 0.4386 2.97 
3 120 0.4856 3.27 
 
The concentration of Crystal Violet at different time interval was 
interpolated from the calibration graph (page no.53). The results were 
correlated with amount of biofilm formed. 
 
Table No16: Quantification of biofilm in S-IV by 
 Crystal Violet method 
 
S.  
No 
Time in hrs Absorbance at 570nm 
Concentration of  
Crystal Violet µg/ml 
1 96 0.4359 2.95 
2 120 0.4913 3.31 
 
The concentration of Crystal Violet at different time interval was 
interpolated from the calibration graph (page no.53). The results were 
correlated with amount of biofilm formed. 
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Determination of Minimal Inhibitory Concentration 
Table No17: Minimal Inhibitory Concentration (MIC) of Ofloxacin 
S. No Microorganisms MIC µg/ml 
1 Staphylococcus aureus S-I 0.4 
2 Staphylococcus aureus S-II 15.6 
3 Staphylococcus epidermidis S-III 3.9 
4 Staphylococcus epidermidis S -IV 15.6 
 
 
Table No18: Minimal Inhibitory Concentration (MIC)  
of Rifampin 
S. No Microorganisms MIC µg/ml 
1 Staphylococcus aureus S-I 0.39 
2 Staphylococcus aureus S-II 0.09 
3 Staphylococcus epidermidis S-III 0.04 
4 Staphylococcus epidermidis S -IV 0.09 
 
The MIC of Ofloxacin against planktonic cells of S-I, SII, 
S-III, and S-IV isolates was 0.4, 15.6, 3.9, 15.6μg/ml respectively and MIC 
of Rifampin against S-I, SII, S-III and S-IV was 0.39, 0.09, 0.04 and 
0.09μg/ml respectively.   
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Determination of Minimal Bactericidal Concentration  
Fig.15: Minimal Bactericidal Concentration of Ofloxacin   
        
 
          
 
 
 
 
 
 
 
 
Table No19: Minimal Bactericidal Concentration 
(MBC) of Ofloxacin  
 
S.No Microorganisms MBC µg/ml 
1 Staphylococcus aureus S-I 1.9 
2 Staphylococcus aureus S-II 125 
3 Staphylococcus epidermidis S-III 15.6 
S- I 
1- Control , 2 -0.48 µg/ml, 3 -
S- II 
1- Control  2 -  15 6  µg/ml  3 -31 2 µg/ml  
S- III 
1- Control, 2 –3.9µg/ml, 3 -7.8 µg/ml, 
S- IV 
1- Control , 2 -  15.6  µg/ml, 3 -31.2 
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4 Staphylococcus epidermidis S -IV 62.5 
 
The MBC of Ofloxacin against Staphylococcus S-I, S-II, S-III and S-
IV were found 1.9,125, 15.6 and 62.5μg/ml respectively.  
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Determination Minimal Bactericidal Concentration 
Fig.16: Minimal Bactericidal Concentration of Rifampin 
   
 
      
 
 
 
 
 
Table No.20: Minimal Bactericidal 
 Concentration (MBC) of Rifampin 
S.No Microorganisms MBC µg/ml 
1 Staphylococcus aureus S-I 1.56 
S- I 
1- Control, 2- 0.39   µg/ml, 3-0.78 
S- II 
1- Control, 2 -  0.09 µg/ml, 3 -0.19 µg/ml, 
S- III 
1- Control, 2 -  0.04  µg/ml, 3 – 
0 09 / l  
S- IV 
1- Control, 2 -  0.09 µg/ml, 3 – 
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2 Staphylococcus aureus S-II 0.39 
3 Staphylococcus epidermidis S-III 0.09 
4 Staphylococcus epidermidis S -IV 0.19 
 
The MBC of Rifampin against Staphylococcus S-I, S-II, S-III and S-
IV showed in the following 1.56, 0.39, 0.09 and 0.19μg/ml. 
 
Fig.17: Effect of Ofloxacin in preventing in-vitro 
 adhesion of Staph.on biomaterial by TTC Method 
         
                         S-I                                                          S-II 
                            
                   S-III                                                         S-IV 
Red Formazan precipitate of TTC not found in tubes containing 
Ofloxacin at MIC and above it indicating prevention of adhesion of S-
I,S-II, S-III and S-IV on biomaterial. 
Table No21: MIC of Ofloxacin in preventing 
adhesion on biomaterial 
M
I
C 
M
I
C 
M
I
C 
M
I
C 
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S. 
No Microorganisms MIC in µg/ml 
1 Staphylococcus aureus S-I 3.9 
2 Staphylococcus aureus S-II 62.5 
3 Staphylococcus epidermidis S-III 15.6 
4 Staphylococcus epidermidis S -IV 31.2 
 
From the Fig no:17,  The tubes containing S-I at 3.9 μg/ml, S-II at 
62.5 μg/ml, S-III at 15.6 μg/ml and S-IV at 31.2 μg/ml indicates the MIC 
value, at  and above which the tubes did not show formation of  red 
formazan precipitate either on the biomaterial surface or in the 
medium. It confirms the above mentioned concentration of Ofloxacin 
was found to be sufficient in preventing the adhesion on biomaterial. 
 
 
Fig.18: Effect of Rifampin in preventing in-vitro  
adhesion of Staph. on biomaterial by TTC Method 
 
           
                            S-I                                   S-II 
           
M
I
C 
M
I
C 
M
I
C 
MI 
C 
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                     S-III                       S-IV 
 Red Formazan precipitate of TTC not found in tubes containing 
Rifampin at MIC and above it indicating prevention of adhesion of S-I, 
S-II, S-III and S-IV on biomaterial.  
Table No22: MIC of Rifampin in preventing  
adhesion on biomaterial 
S. 
No 
Microorganisms MIC µg/ml 
1 Staphylococcus aureus S-I 0.78  
2 Staphylococcus aureus S-II 0.39  
3 Staphylococcus epidermidis S-III 0.78  
4 Staphylococcus epidermidis S -IV 0.19 
 
From the Fig no:18  The tube containing S-I at 0.78μg/ml, S-II at 
0.39μg/ml, S-III at 0.78μg/ml and S-IV at 0.19μg/ml indicates the MIC 
value, at  and above which the tubes did not show formation of  red 
formazan precipitate either on the biomaterial surface or in the 
medium. It confirms the above mentioned concentration of Rifampin 
was found to be sufficient in preventing the adhesion on biomaterial. 
 
 
 
Fig.19: Effect of Ofloxacin in preventing in-vitro biofilm formation of 
Staph. on biomaterial by TTC Method 
 
 36 
MI 
C 
    
 
         S-I       S-II    
 
     
 
 
 
S-III      S- IV                 
  
Red Formazan Precipitate of TTC not found in tubes containing 
Ofloxacin at MIC and above it indicating prevention of biofilm formation 
of S-I, S-II, S-III and S-IV on biomaterial. 
TableNo23: MIC of Ofloxacin in preventing  
biofilm formation on biomaterial 
 
S.No Microorganism MIC µg/ml 
1 Staphylococcus aureus S-I 15.6 
2 Staphylococcus aureus S-II 125 
3 Staphylococcus epidermidis S-III 31.2 
4 Staphylococcus epidermidis S -IV 62.5 
  
From the fig no:19  The  tubes containing S-I at 15.6 μg/ml, S-II at 
125 μg/ml, S-III at 31.2 μg/ml and S-IV at 62.5μg/ml indicates the MIC 
value, at  and above which the tubes did not show formation of  red 
formazan precipitate either on the biomaterial surface or in the medium. 
MI 
C 
MI 
C 
MI 
C 
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It confirms the above mentioned concentration of Ofloxacin was found 
to be sufficient in preventing the biofilm formation on biomaterial. 
 
Fig.20: Effect of Rifampin in preventing in-vitro biofilm formation of 
Staph.on biomaterial by TTC Method 
 
    
S-I                      
 
    S-III  
S-II                     
 
S-IV
MI 
C 
MI 
C 
MI 
C 
MI 
C 
MI 
C 
  S-III 
Results and Discussion 
37 
 
Red Formazan precipitate of TTC not found in tubes containing 
Rifampin at MIC and above it indicating prevention of biofilm 
formation of S-I, S-II, S-III and S-IV on biomaterial. 
Table No24: MIC of Rifampin in preventing 
 biofilm formation on biomaterial 
S.No Microorganisms MIC µg/ml 
1 Staphylococcus aureus S-I 3.12 
2 Staphylococcus aureus S-II 3.12 
3 Staphylococcus epidermidis S-III 0.78 
4 Staphylococcus epidermidis S-IV 0.78 
 
From the Fig no:20,  The tubes containing  S-I at 3.12 μg/ml, S-II at 
3.12 μg/ml, S-III at 0.78 μg/ml and S-IV at 0.78μg/ml indicates the MIC 
value, at  and above which the tubes did not show formation of  red 
formazan precipitate either on the biomaterial surface or in the 
medium. It confirms the above mentioned concentration of Rifampin 
was found to be sufficient in preventing the biofilm formation on 
biomaterial. 
Fig.21: Effect of Ofloxacin in preventing in-vitro mature biofilm of 
Staph.on biomaterial by TTC Method 
 
  
S-I S-II 
MI
C 
M 
I 
C 
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S-III S-IV 
Red Formazan precipitate of TTC not found in tubes containing 
Ofloxacin at MIC and above it indicating prevention of mature biofilm  
of S-I,S-II, S-III and S-IV on biomaterial. 
Table No25: MIC of Ofloxacin to eradicate mature  
biofilm on the biomaterial 
S.No Microorganisms MIC µg/ml 
1 Staphylococcus aureus S-I 250 
2 Staphylococcus aureus S-II 500 
3 Staphylococcus epidermidis S-III 250 
4 Staphylococcus epidermidis S-IV 125 
 
From the Fig no:21  The tubes containing of  S-I at 250μg/ml, S-II 
at 500μg/ml, S-III at250μg/ml and S-IV at 125μg/ml indicates the MIC 
value, at  and above which the tubes did not show formation of  red 
formazan precipitate either on the biomaterial surface or in the 
medium. It confirms the above mentioned concentration of Ofloxacin 
was found to be sufficient to eradicate mature biofilm on biomaterial . 
 
Fig.22: Effect of Rifampin in preventing in-vitro mature biofilm of 
Staph.on biomaterial by TTC Method  
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                 S- I               S- II 
  
           S- III    S- IV 
Red Formazan precipitate of TTC not found in tubes containing 
Rifampin at MIC and above it indicating prevention of mature biofilm  
of S-I,S-II, S-III and S-IV on biomaterial. 
Table No26: MIC of Rifampin to eradicate mature 
 biofilm on the biomaterial 
 
S.No Microorganisms  MIC µg/ml 
1 Staphylococcus aureus S-I 12.5 
2 Staphylococcus aureus S-II 25 
3 Staphylococcus epidermidis S-III 6.25 
4 Staphylococcus epidermidis S-IV 6.25 
   
M 
I 
C 
M 
I 
C 
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From the Fig no: 22 The tubes containing S-I at 12.5μg/ml, S-II at 
25μg/ml, S-III at 6.25μg/ml and S-IV at 6.255μg/ml indicates the MIC 
value, at and above which the tubes did not show formation  red 
formazan precipitate either on the biomaterial surface or in the 
medium. It confirms the above mentioned concentration of Rifampin 
was found to be sufficient to eradicate mature biofilm on biomaterial. 
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RESULTS AND DISCUSSION 
 
Fig.4: Screening of biofilm producers 
 by Tissue Culture Plate method  
 
 
High and moderate slime producers differentiated with Crystal 
Violet staining in 96 well tissue culture plate. 
 
Table No1: Tissue Culture Plate method  
 
S.No Microorganisms Report 
1 Staphylococcus aureus                S-I Strong 
2 Staphylococcus aureus                S-II Strong 
3 Staphylococcus epidermidis  S-III Strong 
4 Staphylococcus epidermidis  S -IV Moderate 
 Control 
  
 SIV-
Moderate  
 
 
 S-III High 
 
 
  S-II High 
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From the Tissue Culture Plate method (Fig.4) it is clear that strains 
S-I, S-II and S-III were uniformly stained by crystal violet on all sides of the 
tissue culture plate, which indicates strong biofilm producing ability. 
Strain S-IV showed moderate biofilm producing ability because the 
intensity of stained crystal violet was less in comparison.  
Fig.5: Screening of biofilm producers by Tube Method 
 
   S-I, S-II, S-III: High, S-IV- Non biofilm producer & C-control.   
Table No2: Tube Method  
 
 
 
 
  Values 
are 
mean + S.E.M (n=3)  
 
S. No Microorganisms Report 
1 Staphylococcus aureus  S-I Strong 
2 Staphylococcus aureus S-II Strong 
3 Staphylococcus epidermidis S-III Strong 
4 Staphylococcus epidermidis S -IV Weak 
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In tube method the strains S-I S-II, and S-III formed thin lined film 
on sides of the wall and bottom of the test tubes which indicates strong 
biofilm producing ability. Strain S-IV showed lesser intensity of stained 
crystal violet in comparison. 
 
  
 
 
 
Fig.6: Screening of biofilm producers  
by Congo Red Agar method 
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S-I Black colonies 
 
                S-III Pink colonies 
 
S-II Black colonies 
 
              S-IV Pink colonies
Results and Discussion 
37 
 
Table No3: Congo Red Agar method  
S.No Microorganisms Report 
1. Staphylococcus aureus  S-I Strong 
2. Staphylococcus aureus  S-II Strong 
3. Staphylococcus epidermidis  S-III Weak 
4. Staphylococcus epidermidis S -IV Weak 
Values are mean + S.E.M (n=3)  
 
In CRA method S-I and S –II strains displayed black colonies with 
dry crystalline consistency confirming the organisms to be strong slime 
producers. S-III and S-IV displayed pink colonies which confirm they are 
weak slime producers. 
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SUMMARY AND CONCLUSION 
 
Biofilm forming ability has been recognized as an important 
virulence factor in Staphylococcal spp. facilitating their persistence 
in the host, evading its defences and allowing bacterial survival at 
high antimicrobial concentrations (Olivera M. et al., 2006). 
Biofilm producing ability does not appear equally in all 
strains (S-I, S-II, S-III and S-IV). The differences observed could 
be a result of the growth conditions used, lack of ability of some 
biofilm to adhere to polystyrene plates or due to different 
adherence mechanisms(Vasudevan .P et al., 2003).  
 The strains S-I, SII, S-III, and S-IV adhered to the 
biomaterial at 12, 48, 48 and 72, hrs respectively. The duration for 
biofilm formation on the biomaterial was almost 72 hrs in all the 3 
strains except S-IV which took 96 hrs for biofilm formation. There 
was no direct relationship between the amount of biofilm formed 
and the initial adhesion extent. High levels of initial adherence do 
not necessarily lead to thick biofilm formation. (Nuno Cerca et al., 
2005). 
Rifampin and Ofloxacin that were used in this study, exerted 
inhibitory action on all the tested strains with respect to preventing 
adhesion, biofilm formation and in eradication of the matured 
biofilm formed. Both these drugs could be used together with 
possible synergistic result. The methods used in this work could be 
Results and Discussion 
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used to study the effect of more effective newer antibacterial 
agents against biofilm forming organisms. Genotyping of biofilm 
forming organisms could also be used in their identification. This 
could be used along with phenotype based identification methods 
that have been used in this study. Our study could have better 
clinical implication if supported with genotypic characterization of 
biofilm forming organisms, especially clinical pathogens. 
Antimicrobial combinations could be tested for possible synergism 
against biofilm forming organisms whose eradication in clinical 
setting, continues to remain a challenge for the physician. 
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